Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, monosodium salt, (11β,16α)-
-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, monosodium salt, (11β,16α)-
structure -
-
CAS No:
1869-92-7
-
Formula:
C22H30FO8P.Na
-
Chemical Name:
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, monosodium salt, (11β,16α)-
-
Synonyms:
Pregna-1,4-diene-3,20-dione,9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-,monosodium salt,(11β,16α)-;Pregna-1,4-diene-3,20-dione,9-fluoro-11β,17,21-trihydroxy-16α-methyl-,21-(dihydrogen phosphate),monosodium salt;Pregna-1,4-diene-3,20-dione,9-fluoro-11β,17,21-trihydroxy-16α-methyl-,21-phosphate,monosodium salt;65184-38-5
-
CAS No:
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, monosodium salt, (11β,16α)- Basic Attributes
494.425
494.14800
217-487-2
DTXSID3047429
29036990
Drug Information
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
Decadron phosphate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, monosodium salt, (11β,16α)- Use and Manufacturing
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Computed Properties
Molecular Weight:494.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:4
Exact Mass:494.14817732
Monoisotopic Mass:494.14817732
Topological Polar Surface Area:144
Heavy Atom Count:33
Complexity:985
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-21-[(iodoacetyl)oxy]-16-methyl-, (11β,16α)-
1893-66-9
-
Pregna-1,4-diene-3,20-dione, 21-[(2,2-dibutyl-1-oxohexyl)oxy]-9-fluoro-11,17-dihydroxy-16-methyl-, (11β,16α)-
78901-95-8
-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-21-(phosphonooxy)-, sodium salt (1:2), (11β,16α)-
1997-15-5
-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isothiazolyl)carbonyl]amino]-7-oxo-, monosodium salt, [2S-(2α,5α,6β)]- Formula
16216-98-1
-
Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11β,16α)- Formula
78806-74-3
-
Pregna-1,4-diene-3,20-dione, 11,21-bis(acetyloxy)-16-methyl-, (11β,16α)- Formula
84682-40-6
-
Glycine, N-(4-aminobenzoyl)-, monosodium salt, hydrate Structure
206658-83-5
-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-21-(phosphonooxy)-, potassium salt (1:2), (11β,16α)- Structure
1881-20-5
-
What is 2-[2-[2-CHLORO-3-[2-[1,3-DIHYDRO-1-(4-SULFOBUTYL-2H-QUINOLINYLIDENE) ETHYLIDENE]-1-CYCLOPENTENE-1-YL]ETHENYL]-1(4-SULFOBUTYL)QUINOLINIUM], INNER SALT, MONOSODIUM SALT
287183-28-2
-
What is Benzoic acid, 4-[[2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-, monosodium salt, (S)-
41748-47-4
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, monosodium salt, (11β,16α)-
SDSRequest for Quotation